Ray McDermott

Researcher Next ID · RN-008263

Researcher · Medicine

Dublin, Ireland

Not currently recruitingFunding unknown

Research interests

Medicine

Prostate Cancer Treatment and Research

PARP inhibition in cancer therapy

Colorectal Cancer Treatments and Studies

Prostate Cancer Diagnosis and Treatment

Cancer Immunotherapy and Biomarkers

Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer
New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1903835
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1712126
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
Journal of Clinical Oncology · 2018 · https://doi.org/10.1200/jco.2017.76.9901
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
The Lancet Oncology · 2017 · https://doi.org/10.1016/s1470-2045(17)30422-9
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1510665

No projects listed.